Cover Image
市場調查報告書

全球無針頭糖尿病管理市場:規模,佔有率,發展,成長率,需求預測

Global Needle-Free Diabetes Management Market Size, Share, Development, Growth and Demand Forecast to 2025

出版商 P&S Market Research Pvt. Ltd 商品編碼 536308
出版日期 內容資訊 英文 101 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球無針頭糖尿病管理市場:規模,佔有率,發展,成長率,需求預測 Global Needle-Free Diabetes Management Market Size, Share, Development, Growth and Demand Forecast to 2025
出版日期: 2017年02月01日 內容資訊: 英文 101 Pages
簡介

本報告提供全球無針頭 (不使用針頭的) 糖尿病管理市場相關調查分析,提供市場規模與預測,各地區分析,競爭情形,企業簡介相關之系統性資訊。

第1章 調查範圍·手法

第2章 摘要整理

第3章 市場預測

  • 簡介
  • 市場機會
  • 推動市場要素
  • 市場阻礙因素

第4章 全球無針頭糖尿病管理市場規模與預測

  • 設備類別
  • 各地區

第5章 全球無針頭糖尿病管理市場:設備類別

  • 治療用
  • 診斷用
  • 人工胰臟市場

第6章 全球無針頭糖尿病管理市場:各地區

  • 北美
  • 歐洲
  • 亞太地區
  • 其他

第7章 競爭分析

  • 波特的五力分析
  • 競爭定位

第8章 與企業簡介策略性發展

  • 主要企業簡介
    • Glide Pharmaceutical Technologies Ltd.
    • Antares Pharma Inc.
    • Zogenix, Inc.
    • Pharmajet, Inc.
    • Inovio Pharmaceuticals, Inc.
    • Tandem Diabetes Care, Inc.
    • Insulet Corporation
    • Medtronic plc
  • 策略性發展

第9章 附錄

目錄

Market Overview:

Needle-free diabetes management refers to treatment, diagnosis and monitoring of diabetic patients without using needles. Needle-free diabetes management devices are used for injecting insulin and monitoring blood glucose level in diabetic patients. Controlling blood glucose levels in diabetes requires administration of insulin in human body, which is conventionally done by injecting insulin with needles. Parenteral dosage forms are intended for administration, as an injection or infusion. Parenteral administration of drug is one of the most widespread methods of drug delivery.

Insulin in delivered with the help of various delivery devices, such as insulin pumps, pen injectors, insulin syringe and jet injectors. Insulin syringes are most commonly used delivery system for self-medication. However, insulin syringe not being convenient option for few, has resulted in development of other devices for the treatment of diabetes.

The key problems associated with parenteral drug delivery are lack of safety, sterility, affordability, accuracy and convenience. Conventional insulin delivery devices have several draw backs such as high cost, chances of needle-stick injuries, and possible infections. These factors lead to increased demand for needle-free diabetes management. Needle-free diabetes management devices are easy and secure to use. These devices are novel systems to introduce insulin into patients without piercing the skin with a needle. Needle-free diabetes treatment devices propel insulin at high speed, which penetrates the skin for intradermal, subcutaneous, or intramuscular administration.

Needle-free diabetes management devices are mainly of three types, including treatment devices, diagnostic devices and artificial pancreas. The treatment devices are used to administer or infuse insulin in diabetic patients, whereas diagnostic devices are used to monitor blood glucose levels without needle. Artificial pancreas is developed for the automatic monitoring of blood sugar levels by functioning similarly as healthy pancreas.

Market Dynamics:

The global needle-free diabetes management market is expected to witness a CAGR of 17.8% during the forecast period, to reach $16,831.5 million by 2025. The increasing awareness regarding the safety issues associated with needles is the key growth driver for the global market. Among the different types of needle-free diabetes management devices, artificial pancreas market is expected to witness the fastest growth during the forecast period.

Opportunity:

The adoption of needle-free diabetes management in the emerging economies is expected to provide huge growth potential for the market, during the forthcoming years. The growth will be driven by the increasing healthcare awareness, increasing healthcare spending, and regulatory initiatives for needle stick injuries. Although the market is growing at a significant rate in the emerging economies, especially in Asia-Pacific and Latin America, there is still massive unexplored market for needle-free diabetes management devices. With the boom in e-commerce industry in Asia, the major manufacturers of the needle-free diabetes management devices are penetrating the untapped market in the region.

Growth Drivers:

The factors driving the growth of the needle-free diabetes management market are growing geriatric population, increasing prevalence of diabetes and technological advancements. The development of technologically advanced diabetes management devices has become necessary to ensure increased healthcare efficiency and productivity. Earlier, diabetic patients needed to prick their fingers to obtain blood sample for frequent glucose level monitoring. However, with the development of advanced biosensors, glucose monitoring has become easy to operate and painless. Also, these devices are designed for use in at home, so patients are capable of monitoring blood glucose level frequently. Similarly, treatment of diabetes has also become needle-free with the development of advanced insulin jet injectors. These devices help patient to painlessly inject drugs themselves, while eliminating the risk of infection and needle-stick injuries associated with the use of insulin delivery through needle.

Competitive Landscape:

The global needle-free diabetes management device manufacturers are focusing on the product innovation to strengthen their position in the global market. Some of the key players in the global market include Medtronic plc, Insulet Corporation, Tandem Diabetes Care, Inc., Inovio Pharmaceuticals, Inc., Pharmajet, Inc., Zogenix, Inc., Antares Pharma Inc., and Glide Pharmaceutical Technologies Ltd.

Scope for Customization:

P&S Market Research offers customization as per specific business requirements of clients. Illustrative customization within the scope of this report includes:

Period of Analysis - Increase in the study period, including historic and forecast years

Geographical Analysis - Increase in country coverage:

Segment Analysis - More granular coverage related to:

  • Country level market breakdown by device type
  • Company Profiles - Wider company coverage in terms of detailed analysis or additional company profiles
  • New custom report - A completely customized report can be provided on the market, specific to a region/ country/ segment

Table of Content

Chapter 1. Research Scope and Methodology

  • 1.1. Market Definition
  • 1.2. Research Scope
    • 1.2.1. Market segmentation by type
    • 1.2.2. Market segmentation by geography
  • 1.3. Research Methodology and Sources

Chapter 2. Executive Summary

  • 2.1. Key Findings
  • 2.2. Research Summary

Chapter 3. Market Outlook

  • 3.1. Introduction
  • 3.2. Opportunity in the Global Needle-Free Diabetes Management Market
    • 3.2.1. Adoption of needle-free diabetes management in emerging markets
  • 3.3. Factors Driving the Growth of the Market and its Impact on Market Forecast
    • 3.3.1. Growing geriatric population
    • 3.3.2. Increasing prevalence of diabetes
    • 3.3.3. Technological advancements
    • 3.3.4. Increasing awareness regarding the safety issues associated with needles
    • 3.3.5. Impact analysis of drivers on market forecast
  • 3.4. Factors Hindering Growth of the Market and its Impact on Market Forecast
    • 3.4.1. Alternative drug delivery methods
    • 3.4.2. Stringent regulatory requirements
    • 3.4.3. Impact analysis of restraints on market forecast

Chapter 4. Global Needle-Free Diabetes Management Market Size and Forecast (2014-2025)

  • 4.1. Global Needle-Free Diabetes Management Market, by Device Type
  • 4.2. Global Needle-Free Diabetes Management Market, by Region

Chapter 5. Global Needle-Free Diabetes Management Market, by Device Type

  • 5.1. Needle-Free Diabetes Treatment Device Market
    • 5.1.1. Global needle-free diabetes treatment device market, by type
      • 5.1.1.1. Insulin pen. jet injector market
        • 5.1.1.1.1. Global insulin pen. jet injector market, by region
      • 5.1.1.2. Insulin patch. pump market
        • 5.1.1.2.1. Global insulin patch. pump market, by region
      • 5.1.1.3. Insulin inhaler market
        • 5.1.1.3.1. Global insulin inhaler market, by region
    • 5.1.2. Global needle-free diabetes treatment device market, by region
  • 5.2. Needle-Free Diabetes Diagnostic Device Market
    • 5.2.1. Global needle-free diabetes diagnostic device market, by region
  • 5.3. Artificial Pancreas Market
    • 5.3.1. Global artificial pancreas market, by region

Chapter 6. Global Needle-Free Diabetes Management Market, by Geography

  • 6.1. North America Needle-Free Diabetes Management Market
    • 6.1.1. North America needle-free diabetes management market, by type
      • 6.1.1.1. North America needle-free diabetes treatment device market, by type
    • 6.1.2. North America needle-free diabetes management market, by country
  • 6.2. Europe Needle-Free Diabetes Management Market
    • 6.2.1. Europe needle-free diabetes management market, by type
      • 6.2.1.1. Europe needle-free diabetes treatment device market, by type
    • 6.2.2. Europe needle-free diabetes management market, by country
  • 6.3. Asia-Pacific Needle-Free Diabetes Management Market
    • 6.3.1. Asia-Pacific needle-free diabetes management market, by type
      • 6.3.1.1. Asia-Pacific needle-free diabetes treatment device market, by type
    • 6.3.2. Asia-Pacific needle-free diabetes management market, by country
  • 6.4. Rest of the World (RoW) Needle-Free Diabetes Management Market
    • 6.4.1. RoW needle-free diabetes management market, by type
      • 6.4.1.1. RoW needle-free diabetes treatment device market, by type
    • 6.4.2. RoW needle-free diabetes management market, by country

Chapter 7. Competitive Analysis

  • 7.1. Porters Five Forces of Competitive Position Analysis
    • 7.1.1. Bargaining power of buyers
    • 7.1.2. Bargaining power of suppliers
    • 7.1.3. Threat of new entrants
    • 7.1.4. Intensity of rivalry
    • 7.1.5. Threat of substitutes
  • 7.2. Competitive Positioning of the Global Needle-Free Diabetes Management Market, by Treatment Device Type

Chapter 8. Company Profiles and Strategic Developments

  • 8.1. Key Company Profiles
    • 8.1.1. Glide Pharmaceutical Technologies Ltd.
      • 8.1.1.1. Business overview
      • 8.1.1.2. Product and service offerings
    • 8.1.2. Antares Pharma Inc.
      • 8.1.2.1. Business overview
      • 8.1.2.2. Product and service offerings
    • 8.1.3. Zogenix, Inc.
      • 8.1.3.1. Business overview
      • 8.1.3.2. Product and service offerings
    • 8.1.4. Pharmajet, Inc.
      • 8.1.4.1. Business overview
      • 8.1.4.2. Product and service offerings
    • 8.1.5. Inovio Pharmaceuticals, Inc.
      • 8.1.5.1. Business overview
      • 8.1.5.2. Product and service offerings
    • 8.1.6. Tandem Diabetes Care, Inc.
      • 8.1.6.1. Business overview
      • 8.1.6.2. Product and service offerings
    • 8.1.7. Insulet Corporation
      • 8.1.7.1. Business overview
      • 8.1.7.2. Product and service offerings
    • 8.1.8. Medtronic plc
      • 8.1.8.1. Business overview
      • 8.1.8.2. Product and service offerings
  • 8.2. Strategic Developments in the Needle-Free Diabetes Management Market

Chapter 9. Appendix

  • 9.1. List of Abbreviations

LIST OF TABLES

  • TABLE 1: SPECIFIC PRIMARY AND SECONDARY SOURCES USED FOR THIS PUBLICATION
  • TABLE 2: GLOBAL NEEDLE-FREE DIABETES MANAGEMENT MARKET SNAPSHOT
  • TABLE 3: DRIVERS FOR THE MARKET: IMPACT ANALYSIS
  • TABLE 4: RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS
  • TABLE 5: GLOBAL NEEDLE-FREE DIABETES MANAGEMENT MARKET, BY DEVICE TYPE, $M (2014 - 2016)
  • TABLE 6: GLOBAL NEEDLE-FREE DIABETES MANAGEMENT MARKET, BY DEVICE TYPE, $M (2017 - 2025)
  • TABLE 7: GLOBAL NEEDLE-FREE DIABETES MANAGEMENT MARKET, BY REGION, $M (2014 - 2016)
  • TABLE 8: GLOBAL NEEDLE-FREE DIABETES MANAGEMENT MARKET, BY REGION, $M (2017 - 2025)
  • TABLE 9: GLOBAL NEEDLE-FREE DIABETES TREATMENT DEVICE MARKET, BY TYPE, $M (2014 - 2016)
  • TABLE 10: GLOBAL NEEDLE-FREE DIABETES TREATMENT DEVICE MARKET, BY TYPE, $M (2017 - 2025)
  • TABLE 11: GLOBAL INSULIN PEN & JET INJECTOR MARKET, BY REGION, $M (2014 - 2016)
  • TABLE 12: GLOBAL INSULIN PEN & JET INJECTOR MARKET, BY REGION, $M (2017 - 2025)
  • TABLE 13: GLOBAL INSULIN PATCH & PUMP MARKET, BY REGION, $M (2014 - 2016)
  • TABLE 14: GLOBAL INSULIN PATCH & PUMP MARKET, BY REGION, $M (2017 - 2025)
  • TABLE 15: GLOBAL INSULIN INHALER MARKET, BY REGION, $M (2014 - 2016)
  • TABLE 16: GLOBAL INSULIN INHALER MARKET, BY REGION, $M (2017 - 2025)
  • TABLE 17: GLOBAL NEEDLE-FREE DIABETES TREATMENT DEVICE MARKET, BY REGION, $M (2014 - 2016)
  • TABLE 18: GLOBAL NEEDLE-FREE DIABETES TREATMENT DEVICE MARKET, BY REGION, $M (2017 - 2025)
  • TABLE 19: GLOBAL NEEDLE-FREE DIABETES DIAGNOSTIC DEVICE MARKET, BY REGION, $M (2014 - 2016)
  • TABLE 20: GLOBAL NEEDLE-FREE DIABETES DIAGNOSTIC DEVICE MARKET, BY REGION, $M (2017 - 2025)
  • TABLE 21: GLOBAL ARTIFICIAL PANCREAS MARKET, BY REGION, $M (2014 - 2016)
  • TABLE 22: GLOBAL ARTIFICIAL PANCREAS MARKET, BY REGION, $M (2017 - 2025)
  • TABLE 23: NORTH AMERICA NEEDLE-FREE DIABETES MANAGEMENT MARKET, BY DEVICE TYPE, $M (2014 - 2016)
  • TABLE 24: NORTH AMERICA NEEDLE-FREE DIABETES MANAGEMENT MARKET, BY DEVICE TYPE, $M (2017 - 2025)
  • TABLE 25: NORTH AMERICA NEEDLE-FREE DIABETES TREATMENT DEVICE MARKET, BY TYPE, $M (2014 - 2016)
  • TABLE 26: NORTH AMERICA NEEDLE-FREE DIABETES TREATMENT DEVICE MARKET, BY TYPE, $M (2017 - 2025)
  • TABLE 27: NORTH AMERICA NEEDLE-FREE DIABETES MANAGEMENT MARKET, BY COUNTRY, $M (2014 - 2016)
  • TABLE 28: NORTH AMERICA NEEDLE-FREE DIABETES MANAGEMENT MARKET, BY COUNTRY, $M (2017 - 2025)
  • TABLE 29: EUROPE NEEDLE-FREE DIABETES MANAGEMENT MARKET, BY DEVICE TYPE, $M (2014 - 2016)
  • TABLE 30: EUROPE NEEDLE-FREE DIABETES MANAGEMENT MARKET, BY DEVICE TYPE, $M (2017 - 2025)
  • TABLE 31: EUROPE NEEDLE-FREE DIABETES TREATMENT DEVICE MARKET, BY TYPE, $M (2014 - 2016)
  • TABLE 32: EUROPE NEEDLE-FREE DIABETES TREATMENT DEVICE MARKET, BY TYPE, $M (2017 - 2025)
  • TABLE 33: EUROPE NEEDLE-FREE DIABETES MANAGEMENT MARKET, BY COUNTRY, $M (2014 - 2016)
  • TABLE 34: EUROPE NEEDLE-FREE DIABETES MANAGEMENT MARKET, BY COUNTRY, $M (2017 - 2025)
  • TABLE 35: ASIA-PACIFIC NEEDLE-FREE DIABETES MANAGEMENT MARKET, BY DEVICE TYPE, $M (2014 - 2016)
  • TABLE 36: ASIA-PACIFIC NEEDLE-FREE DIABETES MANAGEMENT MARKET, BY DEVICE TYPE, $M (2017 - 2025)
  • TABLE 37: ASIA-PACIFIC NEEDLE-FREE DIABETES TREATMENT DEVICE MARKET, BY TYPE, $M (2014 - 2016)
  • TABLE 38: ASIA-PACIFIC NEEDLE-FREE DIABETES TREATMENT DEVICE MARKET, BY TYPE, $M (2017 - 2025)
  • TABLE 39: ASIA-PACIFIC NEEDLE-FREE DIABETES MANAGEMENT MARKET, BY COUNTRY, $M (2014 - 2016)
  • TABLE 40: ASIA-PACIFIC NEEDLE-FREE DIABETES MANAGEMENT MARKET, BY COUNTRY, $M (2017 - 2025)
  • TABLE 41: ROW NEEDLE-FREE DIABETES MANAGEMENT MARKET, BY DEVICE TYPE, $M (2014 - 2016)
  • TABLE 42: ROW NEEDLE-FREE DIABETES MANAGEMENT MARKET, BY DEVICE TYPE, $M (2017 - 2025)
  • TABLE 43: ROW NEEDLE-FREE DIABETES TREATMENT DEVICE MARKET, BY TYPE, $M (2014 - 2016)
  • TABLE 44: ROW NEEDLE-FREE DIABETES TREATMENT DEVICE MARKET, BY TYPE, $M (2017 - 2025)
  • TABLE 45: ROW NEEDLE-FREE DIABETES MANAGEMENT MARKET, BY COUNTRY, $M (2014 - 2016)
  • TABLE 46: ROW NEEDLE-FREE DIABETES MANAGEMENT MARKET, BY COUNTRY, $M (2017 - 2025)
  • TABLE 47: GLIDE PHARMACEUTICAL TECHNOLOGIES LTD. - KEY FACTS
  • TABLE 48: ANTARES PHARMA INC. - KEY FACTS
  • TABLE 49: ZOGENIX, INC. - KEY FACTS
  • TABLE 50: PHARMAJET, INC. - KEY FACTS
  • TABLE 51: INOVIO PHARMACEUTICALS, INC.- KEY FACTS
  • TABLE 52: TANDEM DIABETES CARE, INC. - KEY FACTS
  • TABLE 53: INSULET CORPORATION - KEY FACTS
  • TABLE 54: MEDTRONIC PLC - KEY FACTS

LIST OF FIGURES

  • FIG 1: RESEARCH SCOPE FOR GLOBAL NEEDLE-FREE DIABETES MANAGEMENT MARKET
  • FIG 2: RESEARCH METHODOLOGY FOR GLOBAL NEEDLE-FREE DIABETES MANAGEMENT MARKET
  • FIG 3: PARENTERAL ADMINISTRATION
  • FIG 4: AGING POPULATION AS A PERCENTAGE OF TOTAL POPULATION
  • FIG 5: GLOBAL DIABETIC POPULATION, AGED 20-79 YEARS (2015, 2040)
  • FIG 6: GLOBAL NEEDLE-FREE DIABETES MANAGEMENT MARKET, $M (2014 - 2025)
  • FIG 7: GLOBAL NEEDLE-FREE DIABETES MANAGEMENT MARKET, BY DEVICE TYPE, $M (2014 - 2025)
  • FIG 8: GLOBAL NEEDLE-FREE DIABETES MANAGEMENT MARKET SPLIT, BY DEVICE TYPE (2016)
  • FIG 9: GLOBAL NEEDLE-FREE DIABETES MANAGEMENT MARKET, BY REGION, $M (2014 - 2025)
  • FIG 10: GLOBAL NEEDLE-FREE DIABETES MANAGEMENT MARKET SPLIT, BY REGION (2016)
  • FIG 11: GLOBAL NEEDLE-FREE DIABETES TREATMENT DEVICE MARKET, BY TYPE, $M (2014 - 2025)
  • FIG 12: GLOBAL NEEDLE-FREE DIABETES TREATMENT DEVICE MARKET SPLIT, BY TYPE (2016)
  • FIG 13: GLOBAL INSULIN PEN & JET INJECTOR MARKET, BY REGION, $M (2014 - 2025)
  • FIG 14: GLOBAL INSULIN PEN & JET INJECTOR MARKET SPLIT, BY REGION (2016)
  • FIG 15: GLOBAL INSULIN PATCH & PUMP MARKET, BY REGION, $M (2014 - 2025)
  • FIG 16: GLOBAL INSULIN PATCH & PUMP MARKET SPLIT, BY REGION (2016)
  • FIG 17: GLOBAL INSULIN INHALER MARKET, BY REGION, $M (2014 - 2025)
  • FIG 18: GLOBAL INSULIN INHALER MARKET SPLIT, BY REGION (2016)
  • FIG 19: GLOBAL NEEDLE-FREE DIABETES TREATMENT DEVICE MARKET, BY REGION, $M (2014 - 2025)
  • FIG 20: GLOBAL NEEDLE-FREE DIABETES TREATMENT DEVICE MARKET SPLIT, BY REGION (2016)
  • FIG 21: GLOBAL NEEDLE-FREE DIABETES DIAGNOSTIC DEVICE MARKET, BY REGION, $M (2014 - 2025)
  • FIG 22: GLOBAL NEEDLE-FREE DIABETES DIAGNOSTIC DEVICE MARKET SPLIT, BY REGION (2016)
  • FIG 23: GLOBAL ARTIFICIAL PANCREAS MARKET, BY REGION, $M (2014 - 2025)
  • FIG 24: WORLDWIDE MAJOR MARKETS FOR NEEDLE-FREE DIABETES MANAGEMENT (2025)
  • FIG 25: NORTH AMERICA NEEDLE-FREE DIABETES MANAGEMENT MARKET, BY DEVICE TYPE, $M (2014 - 2025)
  • FIG 26: NORTH AMERICA NEEDLE-FREE DIABETES MANAGEMENT MARKET SPLIT, BY DEVICE TYPE (2016)
  • FIG 27: NORTH AMERICA NEEDLE-FREE DIABETES TREATMENT DEVICE MARKET, BY TYPE, $M (2014 - 2025)
  • FIG 28: NORTH AMERICA NEEDLE-FREE DIABETES TREATMENT DEVICE MARKET SPLIT, BY TYPE (2016)
  • FIG 29: NORTH AMERICA NEEDLE-FREE DIABETES MANAGEMENT MARKET, BY COUNTRY, $M (2014 - 2025)
  • FIG 30: NORTH AMERICA NEEDLE-FREE DIABETES MANAGEMENT MARKET SPLIT, BY COUNTRY (2016)
  • FIG 31: EUROPE NEEDLE-FREE DIABETES MANAGEMENT MARKET, BY DEVICE TYPE, $M (2014 - 2025)
  • FIG 32: EUROPE NEEDLE-FREE DIABETES MANAGEMENT MARKET SPLIT, BY DEVICE TYPE (2016)
  • FIG 33: EUROPE NEEDLE-FREE DIABETES TREATMENT DEVICE MARKET, BY TYPE, $M (2014 - 2025)
  • FIG 34: EUROPE NEEDLE-FREE DIABETES TREATMENT DEVICE MARKET SPLIT, BY TYPE (2016)
  • FIG 35: EUROPE NEEDLE-FREE DIABETES TREATMENT DEVICE MARKET, BY COUNTRY, $M (2014 - 2025)
  • FIG 36: EUROPE NEEDLE-FREE DIABETES MANAGEMENT MARKET SPLIT, BY COUNTRY (2016)
  • FIG 37: ASIA-PACIFIC NEEDLE-FREE DIABETES MANAGEMENT MARKET, BY DEVICE TYPE, $M (2014 - 2025)
  • FIG 38: ASIA-PACIFIC NEEDLE-FREE DIABETES MANAGEMENT MARKET SPLIT, BY DEVICE TYPE (2016)
  • FIG 39: ASIA-PACIFIC NEEDLE-FREE DIABETES TREATMENT DEVICE MARKET, BY TYPE, $M (2014 - 2025)
  • FIG 40: ASIA-PACIFIC NEEDLE-FREE DIABETES TREATMENT DEVICE MARKET SPLIT, BY TYPE (2016)
  • FIG 41: ASIA-PACIFIC NEEDLE-FREE DIABETES MANAGEMENT MARKET, BY COUNTRY, $M (2014 - 2025)
  • FIG 42: ASIA-PACIFIC NEEDLE-FREE DIABETES MANAGEMENT MARKET SPLIT, BY COUNTRY (2016)
  • FIG 43: ROW NEEDLE-FREE DIABETES MANAGEMENT MARKET, BY DEVICE TYPE, $M (2014 - 2025)
  • FIG 44: ROW NEEDLE-FREE DIABETES MANAGEMENT MARKET SPLIT, BY DEVICE TYPE (2016)
  • FIG 45: ROW NEEDLE-FREE DIABETES TREATMENT DEVICE MARKET, BY TYPE, $M (2014 - 2025)
  • FIG 46: ROW NEEDLE-FREE DIABETES TREATMENT DEVICE MARKET SPLIT, BY TYPE (2016)
  • FIG 47: ROW NEEDLE-FREE DIABETES MANAGEMENT MARKET, BY COUNTRY, $M (2014 - 2025)
  • FIG 48: ROW NEEDLE-FREE DIABETES MANAGEMENT MARKET SPLIT, BY COUNTRY (2016)
  • FIG 49: PORTER'S FIVE FORCES OF COMPETITIVE POSITION ANALYSIS
  • FIG 50: COMPETITIVE POSITIONING OF THE GLOBAL NEEDLE-FREE DIABETES MANAGEMENT MARKET, BY TREATMENT DEVICE TYPE
Back to Top